📰 Nasdaq Acst News
Nasdaq Acst News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Acst. Real-time updates on events, politics, business and more.
May 4, 2024
Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.75 and traded as high as $3.08. Acasti Pharma shares last traded at $2.96, with a volume of 13,180 shares trading hands. Analyst Ratings Changes Separately, Craig […]
April 28, 2024
Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 3,800 shares, an increase of 171.4% from the March 31st total of 1,400 shares. Approximately 0.1% of the company’s shares are sold short. Based on an average trading volume […]
April 5, 2024
Shares of Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.65 and traded as high as $3.41. Acasti Pharma shares last traded at $3.38, with a volume of 34,601 shares traded. Wall Street Analysts Forecast Growth […]
February 14, 2024
Acasti Pharma (NASDAQ:ACST – Get Free Report) released its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Down 6.1 % Shares of Acasti Pharma stock opened at $2.45 on Wednesday. Acasti Pharma has a 1 […]
February 13, 2024
Acasti Pharma (NASDAQ:ACST – Get Free Report) announced its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Performance ACST stock opened at $2.61 on Tuesday. Acasti Pharma has a one year low […]
February 13, 2024
Acasti Pharma (NASDAQ:ACST – Get Free Report) released its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Up 6.5 % Shares of NASDAQ ACST opened at $2.61 on Tuesday. The firm has a market cap […]
January 23, 2024
Acasti Pharma (NASDAQ:ACST – Get Free Report) and XBiotech (NASDAQ:XBIT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Profitability This table compares Acasti Pharma and XBiotech’s […]
July 8, 2023
Acasti Pharma Inc. (NASDAQ:ACST – Free Report)’s stock is set to reverse split on Monday, July 10th. The 1-6 reverse split was announced on Monday, July 10th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, July 10th. Acasti Pharma Stock Down 12.5 % Shares of ACST traded […]
June 17, 2023
Shares of Acasti Pharma Inc. (NASDAQ:ACST – Get Rating) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.53 and traded as high as $0.58. Acasti Pharma shares last traded at $0.57, with a volume of 150,943 shares traded. Acasti Pharma Price Performance The stock […]
June 1, 2023
Shares of Acasti Pharma Inc. (NASDAQ:ACST – Get Rating) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.52 and traded as high as $0.56. Acasti Pharma shares last traded at $0.56, with a volume of 72,987 shares trading hands. Wall […]